Generics Firms Swap Tendering For Price Cuts In Canada
Generic drug manufacturers in Canada have agreed to price cuts of up to 40% to stave off tendering.
You may also be interested in...
The prices of patented medicines overall are expected to go down in Canada under new proposed regulatory amendments.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.